Cytokinetics, Inc. Announces Data Relating to GSK-923295 and SB-743921 Presented at the 2008 EORTC-NCI-AACR International Symposium

SOUTH SAN FRANCISCO, CA--(Marketwire - October 23, 2008) - Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that three posters containing data on GSK-923295, an inhibitor of centromere-associated protein E (CENP-E), and one poster containing data on SB-743921, an inhibitor of kinesin spindle protein (KSP), were presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics held at the Geneva Palexpo, Geneva, Switzerland.

Back to news